Skip to content
goodwin-final-color Color Goodwin logo
  • Manufacturing Solutions
    • Analytical Method Development
    • Clinical GMP Manufacturing Services
    • Upstream Development
    • Downstream Development
    • Aseptic Fill & Finish
    • Bioconjugation
  • Support Solutions
    • Regulatory & CMC Support
    • Quality Control
    • Quality Assurance
    • Project Management
    • Consulting Services
    • Cell Line Development
  • Applications
    • COVID-19
    • Exosomes
    • Biosimilars & Biobetters
    • Multispecific Antibodies & Antibody Fragments
  • About
    • Who We Are
    • Leadership
    • Board of Directors
    • Facilities and Location
    • Why Goodwin Biotechnology?
    • Goodwin Awards
    • Collaborations & Partnerships
    • News
      • Press Releases
      • Upcoming Events
      • In the News
      • Publications & Patents
    • Careers
  • Contact Us
  • Manufacturing Solutions
    • Analytical Method Development
    • Clinical GMP Manufacturing Services
    • Upstream Development
    • Downstream Development
    • Aseptic Fill & Finish
    • Bioconjugation
  • Support Solutions
    • Regulatory & CMC Support
    • Quality Control
    • Quality Assurance
    • Project Management
    • Consulting Services
    • Cell Line Development
  • Applications
    • COVID-19
    • Exosomes
    • Biosimilars & Biobetters
    • Multispecific Antibodies & Antibody Fragments
  • About
    • Who We Are
    • Leadership
    • Board of Directors
    • Facilities and Location
    • Why Goodwin Biotechnology?
    • Goodwin Awards
    • Collaborations & Partnerships
    • News
      • Press Releases
      • Upcoming Events
      • In the News
      • Publications & Patents
    • Careers
  • Contact Us

News

News / Page 3

Radimmune Therapeutics Selected Goodwin Biotechnology for Process Development through cGMP Manufacturing of their IgG Monoclonal Antibody and Conjugate.

  • November 14, 2018

Telix Pharmaceuticals Selects Goodwin Biotechnology as Manufacturing Scale‐up Partner

  • May 2, 2018

Goodwin Biotechnology was named “Biologics cGMP Manufacturer of the Year 2018” by Global Health & Pharma News

  • March 20, 2018

Goodwin Biotechnology Weathered Hurricane Irma Unscathed

  • September 15, 2017

Q&A with Karl Pinto, CEO of Goodwin Biotechnology, Inc. a Contract Development and Manufacturing Organization helping Biotechnology Companies take their Biologics from Lab to the Clinic

  • August 1, 2017
Previous 1 2 3 4 5 … 14 Next

1850 N.W. 69th Avenue Plantation, FL 33313 USA 800-814-8600

  • Facebook
  • Twitter
  • LinkedIn
  • Manufacturing Solutions
    • Analytical Method Development
    • Clinical GMP Manufacturing Services
    • Upstream Development
    • Downstream Development
    • Aseptic Fill & Finish
    • Bioconjugation
  • Support Solutions
    • Regulatory & CMC Support
    • Quality Control
    • Quality Assurance
    • Project Management
    • Consulting Services
    • Cell Line Development
  • Applications
    • COVID-19
    • Exosomes
    • Biosimilars & Biobetters
    • Multispecific Antibodies & Antibody Fragments
  • Who We Are
    • Leadership
    • Board of Directors
    • Facilities & Location
    • Why Goodwin Biotechnology?
    • Goodwin Awards
    • Collaborations & Partnerships
    • News
    • Careers
© 2021 Goodwin Biotechnology Inc. All Rights Reserved.
  • Privacy Policy
  • Sitemap